Kazia Therapeutics (KZIA) Interest & Investment Income (2009 - 2010)

Kazia Therapeutics (KZIA) posted Interest & Investment Income of $256370.5 for Q2 2010, down 68.24% on a QoQ basis from $807149.5 in Q4 2009.

Kazia Therapeutics (KZIA) Interest & Investment Income (2009 - 2010) Analysis & Trends

Kazia Therapeutics' Interest & Investment Income history runs 2 years deep, the most recent figure standing at $256370.5 for Q2 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 48.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 19.51 Mn
10 Kazia Therapeutics 19.19 Bn 19.19 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2010 256,370.52
Dec 31, 2009 807,149.46